Cetuximab in metastatic colorectal cancer: profile report

By Adis International Limited  

Drugs & Therapy Perspectives, Vol. 20, Iss. 6, 2004-06 ,pp. : 7-9

Adis International

Access to resources Recommend Favorite

Use of Bevacizumab in Metastatic Colorectal Cancer: Report from the Mexican Opinion and Analysis Forum on Colorectal Cancer Treatment with Bevacizumab (September 2009)

By Zinser-Sierra Juan W.  

Drugs in R&D, Vol. 11, Iss. 2, 2011-06 ,pp. : 101-111

Adis International

Access to resources Recommend Favorite

Case-Report: Folfoxiri Plus Bevacizumab in “Poor-Risk” Liver-Only Metastatic Colorectal Cancer: Case Report and State-of-the-Art

By  

Clinical Cancer Drugs, Vol. 1, Iss. 1, 2014-01 ,pp. : 78-83

Bentham Science Publishers

Access to resources Recommend Favorite

Bevacizumab an improvement on standard therapy in colorectal cancer

By  

Inpharma, Vol. 1, Iss. 1399, 2003-01 ,pp. : 7-8

Adis International

Access to resources Recommend Favorite

Bevacizumab: A Review of its Use in Metastatic Colorectal Cancer

By McCormack Paul L.   Keam Susan J.  

Drugs, Vol. 68, Iss. 4, 2008-01 ,pp. : 487-506

Adis International

Access to resources Recommend Favorite